Collection of Samples of Bone Marrow Aspiration From Patients With Myelodysplastic Syndrome
NCT06144515 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-06-22
Summary
The study Objective is to collect samples of bone marrow aspirates and peripheral blood of patients with MDS for use in non-clinical research to investigate mitochondrial function sequence and effect of mitochondrial augmentation.
Conditions
Interventions
- PROCEDURE
-
Blood test
Blood is collected in order to perform in vitro research: 1. If a routine blood test is performed for clinical tests, the sponsor will receive the results of the Complete blood count (CBC) and an additional blood sample from the same puncture of 20ml to maximum 40ml will be collected for this study. 2. If no routine blood test is performed for clinical tests, a CBC will be performed for the study and an additional blood sample of 20ml to maximum 40ml will be collected. Additional Bone marrow (BM) material will be obtained from the same puncture performed for routine clinical tests:
Sponsors & Collaborators
-
Minovia Therapeutics Ltd.
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-02-09
- Primary Completion
- 2025-12-31
- Completion
- 2026-03-01
Countries
- Israel
Study Locations
More Related Trials
-
5-azacytidine Treatment Versus 5-azacytidine Followed by Allogeneic Stem Cell Transplantation in Elderly Patients With Myelodysplastic Syndrome (MDS)
NCT01404741 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine (AZA) in Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
NCT02319369 ·Status: TERMINATED ·Phase: PHASE1
-
The National Myelodysplastic Syndromes (MDS) Study
NCT02775383 ·Status: COMPLETED
-
Immunophenotyping of Blood Cells in the Diagnosis Work-up of Myelodysplastic Syndromes
NCT03621241 ·Status: RECRUITING
-
A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS)
NCT00230321 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms
NCT02084563 ·Status: COMPLETED ·Phase: PHASE2
-
Biocollection in MyeloDysplastic Syndrome (P-MDS)
NCT04869683 ·Status: RECRUITING ·Phase: NA
-
Monitoring Mutational Burden in Low Risk MDS Patients Using Sequential Peripheral Blood Samples
NCT04251078 ·Status: RECRUITING
-
Evaluation of Azacitidine in Transfusion Dependent Patients With Low-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)
NCT01048034 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Study of Molecular Predictors of Survival in Myelodysplastic Syndromes
NCT02619565 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of AS101 to Treat Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients
NCT01010373 ·Status: SUSPENDED ·Phase: PHASE2
-
Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome
NCT00003790 ·Status: COMPLETED
-
A Phase II Study of Maintenance With Azacitidine in MDS Patients
NCT00446303 ·Status: TERMINATED ·Phase: PHASE2
-
Erythropoietin (EPO) and Granulocyte-Colony Stimulating Factor (G-CSF) for Low-Risk Myelodysplastic Syndromes (MDS)
NCT00234143 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine
NCT02489929 ·Status: UNKNOWN ·Phase: NA
-
Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
NCT00778375 ·Status: COMPLETED ·Phase: PHASE2
-
2 Arm Study of Clofarabine IV in MDS Patients
NCT00422032 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating in Vivo AZA Incorporation in Mononuclear Cells Following Vidaza or CC486
NCT03493646 ·Status: COMPLETED ·Phase: PHASE2
-
AML-MDS Novel Prognostic Tests Clinical Study
NCT01685619 ·Status: COMPLETED
-
Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome
NCT00002547 ·Status: COMPLETED ·Phase: PHASE2
-
Collection of Sequential Samples From Patients With Malignant Myeloid Hemopathy for the Study of Treatment Resistance
NCT05602168 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Fludarabine and Cytarabine in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
NCT01019317 ·Status: COMPLETED ·Phase: PHASE2
-
5-Fluoro-2'-Deoxycytidine and Tetrahydrouridine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
NCT01041443 ·Status: COMPLETED ·Phase: PHASE1
-
Therapy Protocol Acute Lymphoblastic Leukemia Stem Cell Transplantation International
NCT00861679 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With Higher-risk MDS
NCT06109064 ·Status: RECRUITING ·Phase: PHASE2